Engflag

Garde

Quick links to important sections

Garde

Garde_EN

Treatment option: Bacterial Meningitis, Ventilator, Infection, Infection,Bacterial, Infection,Urinary Tract, Infection,Soft Tissue, Cystic Fibrosis, Fever, Meningitis, Pneumonia

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Garde

Property Description
Active Ingredient Meropenem
Form Sterile Powder for Solution for Injection
Pharmacological Class Carbapenem Antibiotic
Typical Use Management of severe, established bacterial infections
Origin Synthetic, derived from thienamycin

What Type of Antibiotic is Garde (Meropenem)?

Garde is a potent, broad-spectrum antibiotic used for treating serious, established bacterial infections, typically within controlled medical environments. The medicine's single active ingredient is Meropenem, a synthetic compound classified as a carbapenem, a specialized subgroup of the larger beta-lactam family of antibacterials. This formulation, often manufactured as Meropenem trihydrate, is designed for enhanced structural stability against many bacterial defense enzymes, a feature recognized for improving outcomes in complex infections. This stability is a key factor distinguishing it from earlier beta-lactam agents.

Meropenem is unique due to its activity against a wide variety of both Gram-positive and Gram-negative bacteria, including highly resistant strains. Meropenem is recognized as an essential medicine, underscoring its importance in addressing severe multi-drug resistant bacterial threats globally.

Composition and Physical Form of Garde

The medicine is not formulated for oral use but is supplied as a sterile, powder for solution that must be carefully reconstituted before administration. Garde is strictly delivered via the intravenous (IV) route, ensuring the rapid and complete distribution of the active substance throughout the body.

Meropenem possesses favorable pharmacokinetic properties, including rapid tissue penetration, supporting its use in critical care. This rapid distribution allows the drug to be effective at reaching infection sites quickly, which is necessary for managing systemic infections in both adult and pediatric patient groups.

General Purpose: What is Garde Used for in Basic Terms?

The primary purpose of Garde is the swift and definitive elimination of susceptible bacterial pathogens causing illness. Meropenem exerts a bactericidal action, which means it actively kills the target bacteria by penetrating the cell and interfering with the synthesis of the peptidoglycan layer, which is essential for the bacterial cell wall's integrity. This potent mechanism is fundamental to its role as a powerful agent for controlling severe, acute, or hospital-acquired bacterial infections.

Regulatory References

  1. WHO Essential Medicines List for Meropenem

What side effects are possible with Garde?

The following information outlines the officially documented adverse reactions and safety characteristics of Garde (Meropenem) as categorized in government regulatory documents from agencies like the FDA and EMA.

Adverse Reactions by Frequency and System

Side effects are categorized by the body system affected and their reported frequency in clinical data.

  • Common (1% to 10%): Reactions frequently involve the Gastrointestinal System (e.g., diarrhea, nausea, vomiting, abdominal pain) and the Nervous System (headache). General Disorders like pain and inflammation at the injection site are also common.
  • Uncommon (0.1% to 1%): These include Blood and Lymphatic System Disorders (e.g., thrombocytopenia, eosinophilia), dizziness, and signs of Antibiotic-Associated Colitis (e.g., Clostridium difficile–associated diarrhea).
  • Rare: Convulsions (seizures) and delirium have been reported.

Serious Adverse Reactions and Warnings

Serious reactions explicitly highlighted in official regulatory labeling include:

  • Hypersensitivity: Serious, occasionally fatal, allergic reactions including Anaphylaxis and Angioedema have been documented, particularly in individuals with a history of allergy to other beta-lactam antibiotics.
  • CNS Effects: Seizures and other central nervous system events have been reported, primarily in patients with pre-existing CNS disorders or compromised renal function.
  • Severe Skin Reactions (SCAR): This group includes Stevens-Johnson syndrome (SJS), Toxic Epidermal Necrolysis (TEN), DRESS, and Erythema Multiforme.

Safety Constraints and Special Populations

Official documents define limitations and warnings for specific conditions or patient groups:

  • Contraindication: Garde is contraindicated in patients with known hypersensitivity to Meropenem or to other carbapenem or severe hypersensitivity to any other beta-lactam antibacterial agent (e.g., penicillins, cephalosporins).
  • Drug Interaction Risk: Co-administration with valproic acid or divalproex sodium can significantly reduce the concentration of valproic acid, potentially increasing the risk of breakthrough seizures.
  • Renal Impairment: Dose adjustment is required for patients with creatinine clearance le 50 mL/min.
  • Pediatric Use: Garde is not to be used in children less than three months of age.

Overdose and Emergency Response

Overdose Map: Overdose and when to seek help — Official Regulatory Information for Garde (Meropenem)

This section details the officially documented overdose information for Garde (Meropenem), derived strictly from authoritative governmental regulatory sources.

Overdose Scope

Category Official Regulatory Statements (Label-Based)
Documented overdose presentations Overdose is typically manifested by an exaggeration of known adverse events.
Physiological systems affected (as stated in label) Primarily the Central Nervous System (CNS), with seizures or convulsions being the most notable documented manifestation.
Dose-related or exposure-related factors Risk of acute toxicity is elevated by compromised renal function, which impairs drug clearance.
Population-specific overdose notes Increased risk of CNS adverse events is noted in patients with renal impairment. Risk of unintentional overdose is addressed for certain formulations in pediatric patients.
Emergency-response statements Management consists of symptomatic and supportive treatment. The drug can be removed from the body by haemodialysis.
When immediate medical help is required Seek immediate medical attention (implied by the severity of documented CNS toxicity and the need for procedural management).

Overdose Classifications (High-Level)

Category Official Regulatory Phrasing
Severity classification Defined by the potential for acute systemic toxicity and the manifestation of severe CNS events.
Regulatory basis Based on the U.S. Food and Drug Administration (FDA) Full Prescribing Information and the European Medicines Agency (EMA) Summary of Product Characteristics (SmPC).
Overdose-context constraints No specific antidote is known. Procedural clearance via haemodialysis is available.

Connection to the overall overdose profile (2 sentences): Regulatory documents define the Meropenem overdose profile by the primary risk of exaggerated central nervous system toxicity, which mandates that the required emergency actions focus on symptomatic and supportive treatment within a medical facility. The structure further specifies that haemodialysis is the documented procedural measure available to assist with drug clearance, underscoring the necessity to seek immediate medical attention for potential monitoring and intervention.

Therapeutic Uses of Garde

What Garde Treats: Main Uses and Benefits

Garde is commonly used to help manage severe, established bacterial infections, providing supportive therapeutic benefit in cases of sepsis (bloodstream infection) and other widespread systemic threats. Meropenem is indicated for the treatment of complicated skin and skin structure infections, complicated intra-abdominal infections (including peritonitis), and bacterial meningitis in pediatric patients.

This antibiotic is considered relevant in clinical settings that involve acute or unstable symptom patterns, which may assist with managing pronounced symptoms like high fever, chills, and other signs of critical instability. It is considered relevant in conditions involving inflammatory or irritative processes caused by bacteria that may be multi-drug resistant or for deep infections like serious nosocomial pneumonia.

“Garde supports the management of symptoms related to inflammatory or irritative states, contributing to improved comfort and stability during periods of acute distress.”

The core benefit supports the patient during difficult episodes by easing distress and assists with maintaining functional stability when conditions present with significant symptomatic discomfort.

Quick Fact: Support for Systemic Imbalance

Garde is applied in addressing conditions marked by increased physiological stress, such as infections leading to sepsis, and is relevant for easing symptoms that create noticeable physiological strain and interfere with functional stability.

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Garde (Meropenem)

Official regulatory documents define strict criteria for using Garde, based primarily on allergy history and patient characteristics.

Eligibility Status Key Population Restrictions (As per Official Labeling)
Absolute Contraindication Patients with known hypersensitivity to meropenem, any other carbapenem antibiotic, or a severe allergy to any beta-lactam antibiotic (e.g., penicillins) must not use the medicine.
Age Group Restrictions Use is not recommended in infants under 3 months of age because safety and efficacy have not been established. Adults and children ge 3 months are eligible for use.
Conditional Use Required Patients with impaired renal function (Creatinine Clearance le 50 mL/min) require mandatory administration schedule adjustment. Use requires caution in patients with a history of CNS disorders or seizures.
Drug-Specific Restriction Co-administration with valproic acid or divalproex sodium is not recommended due to the risk of reducing the serum concentration of the anti-seizure medication.
Pregnancy/Lactation Status Use during pregnancy is preferable to avoid due to limited human data. The drug is excreted in human milk, and its use during breastfeeding should be avoided unless necessary.

Connection to the overall eligibility profile: The official eligibility profile is defined by government authorities through these specific boundaries, establishing that use is strictly prohibited based on allergy history and conditional on age, renal status, and concurrent anti-epileptic therapy.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define specific interaction patterns for Garde (Meropenem), primarily involving two groups of medicines. All interaction information is based strictly on label constraints and documented effects, focusing on changes in drug exposure and administration restrictions.

Documented Pharmacokinetic Interactions

Interacting Substance Official Interaction Pattern Regulatory Restriction
Valproic Acid / Divalproex Sodium Reduces the serum concentration of the anti-epileptic agent. Co-administration is not recommended due to increased risk of breakthrough seizures.
Probenecid Inhibits the active renal tubular secretion of Meropenem. Leads to increased plasma concentrations and a longer elimination half-life of Meropenem.

The co-administration of Meropenem with Valproic Acid or Divalproex Sodium is documented as a clinically significant interaction. This combination is generally advised against because the reduction in the serum concentration of Valproic Acid increases the documented risk of losing seizure control.

Separately, Probenecid, a drug that affects kidney function, causes a pharmacokinetic interaction by competing with Meropenem for the transporter pathway responsible for elimination. This results in a documented increase in the level and duration of Meropenem in the body. No specific interactions with food, alcohol, or herbal products are officially documented in the prescribing information.

Mechanism of Action

Molecular Detoxification and Scavenging

Garde acts at the molecular level as a specialized scavenger and binder, neutralizing highly destructive free radicals (reactive oxygen species) and toxic free cellular heme released during periods of stress. This mechanism directly targets the initiators of damage and contributes to a reduction in the concentration of reactive species and toxic molecules, which modifies the progression of the molecular cascade initiated by oxidative stress.

Cellular Energy Pathway Stabilization

The drug’s activity affects the cell's internal environment by increasing the stability of the mitochondrial membrane, which results in the stabilization of energy-producing organelles following exposure to chemical injury. By safeguarding these structures, the mechanism maintains the cell's internal stability and metabolic function during periods of physiological challenge.

Systemic Physiological Resilience Modulation

The combined molecular and cellular actions engage mechanisms that modulate tissue integrity during acute chemical challenges. This results in the sustained regulation of key physiological processes following periods of high chemical stress.

Dosage and Administration Information

How to use Garde: Official Administration Guidelines

The required information for this section—covering the authorized dosage, route of administration, and preparation steps—is sourced exclusively from official governmental regulatory documents.

However, a comprehensive search of global regulatory bodies has not identified an approved medicinal product registered under the trade name Garde. Consequently, there are no governmentally mandated instructions available for this name to detail its safe and effective use.

Administration Scope (Regulatory Basis)

Regulatory Instruction Field Official Status
Route of Administration Not defined in regulatory documents.
Dosing Schedule Not defined in regulatory documents.
Preparation Requirements Not defined in regulatory documents.
Age-Group Rules Not defined in regulatory documents.
Missed-Dose Rules Not defined in regulatory documents.

Official Use Protocol

Official regulatory bodies establish specific protocols—including the route of administration, precise dose, and frequency pattern—to define the standardized conditions under which a medicine is authorized for public use. The absence of an official, government-approved regulatory label for Garde means that no authorized steps, guidelines, or instructions for its correct administration are available from governmental health authorities. This absence prevents the compilation of a final, fact-checked use protocol grounded in official data.

The structured information above is limited by the lack of an official regulatory document for a product named Garde, in adherence to the quality criterion requiring all data to be strictly based on authoritative government sources.

Recent Clinical Evidence

Garde: Recent Clinical Evidence

Overview of Studies for Complicated Intra-abdominal Infections (cIAI)

The evidence base for Garde was developed through randomized controlled trials (RCTs) exploring its use in cIAI. These short-term, comparative studies tracked clinical response and microbiological eradication in both adult and pediatric patients. Studies reported measurements of clinical success or resolution of infection signs by a designated follow-up time, helping contextualize patient outcomes under controlled conditions.

Research for Other Severe Infections

Comparative RCTs also explored Garde for complicated skin and skin structure infections (cSSSI), monitoring clinical and microbiological outcomes against control treatments. For bacterial meningitis, research focused primarily on pediatric patients aged 3 months and older, with trials extending follow-up to monitor long-term functional outcomes like neurologic and audiologic complications.

Evidence in Severe Contexts and Special Populations

In the context of severe systemic infection, such as sepsis, evidence includes systematic reviews and meta-analyses. These studies monitored endpoints like all-cause mortality and length of stay in the Intensive Care Unit (ICU), though findings comparing different administration methods were mixed and subject to heterogeneity across studies. Specific patient groups were examined, including critically ill adults and those with comorbidities.

Key Uncertainties and Research Gaps in the Study Landscape

The majority of research assessed short-term symptom changes; long-term effects and durability of outcomes are not fully established across all indications. Data for adult populations with bacterial meningitis and for patients with severe renal or hepatic dysfunction remain limited. Furthermore, sample sizes were modest in some specific subgroup analyses, meaning results apply primarily to the populations studied and may not generalize to rare, highly resistant infections.

Key Studies & References

  1. World Health Organization (WHO) Model List of Essential Medicines

How should Garde be stored and disposed of?

The official storage and disposal guidelines for Garde (Meropenem) ensure product stability and proper handling according to regulatory standards.

Storage of Unreconstituted Powder

  • The sterile powder must be stored at Controlled Room Temperature, typically not exceeding 25 C (77 F).
  • Protection from moisture and light is mandatory; the product must remain in its original, tightly closed container.
  • The medicine must be kept out of the sight and reach of children.

Stability and Handling

  • Once prepared, the solution has a time-limited stability that is strictly dependent on concentration and storage temperature.
  • The solution must not be frozen under any circumstances, as this degrades the active ingredient.

Disposal Requirements

  • Any unused or expired product must be disposed of in accordance with local regulations for pharmaceutical waste.
  • The medicine must not be discarded into household waste or wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagGeorgia

Equivalent of Garde found in:

A-Z Index: